ALK and neoplasm: NGS of the pericardial effusion (520-gene panel, Burning Rock Biotech, Guangzhou, China)detected the original ALK rearrangement, and a novel KIF5B-RET fusion (K15:R12 allele frequency AF: 31.86%, tumor mutation burden:4.99 mutations/Mb).